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Abstract
Background: Users of microarray technology typically strive to use universally acceptable data
analysis strategies to determine significant expression changes in their experiments. One of the
most frequently utilised methods for gene expression data analysis is SAM (significance analysis of
microarrays). The impact of selection thresholds, on the output from SAM, may critically alter the
conclusion of a study, yet this consideration has not been systematically evaluated in any
publication.
Results: We have examined the effect of discrete data selection criteria (qualification criteria for
inclusion) and response thresholds (out-put filtering) on the number of significant genes reported
by SAM. The use of a reduced data set by applying arbitrary restrictions vis-à-vis abundance calls
(e.g. from D-chip) or application of the fold change (FC) option within SAM (named the FC hurdle
hereafter), can substantially alter the significant gene list when running SAM in Microsoft Excel. We
determined that for a given final FC criteria (e.g. 1.5 fold change) the FC hurdle applied within
Microsoft Excel SAM alters the number of reported genes above the final FC criteria. The reason
is that the FC hurdle changes the composition of the control data set, such that a different
significance level (q-value) is obtained for any given gene. This effect can be so large that it changes
subsequent post hoc analysis interpretation, such as ontology overrepresentation analysis.
Conclusion: Our results argue for caution when using SAM. All data sets analysed with SAM could
be reanalysed taking into account the potential impact of the use of arbitrary thresholds to trim
data sets before significance testing.
Background
Response thresholds and exclusion criteria are applied
when presenting a summary of a microarray study; other-
wise the data set can be unmanageable. The precise effect
of such criteria is, however, rarely discussed or investi-
gated. We believe that many researchers are typically not
aware of the effect that their chosen thresholds or 'qualifi-
cation' criteria have had on their final set of "significant
genes". A common example would be data exclusion. In
studies using the Affymetrix platform the selection criteria
typically uses the absent, moderate or present 'call' sys-
tem, calculated with algorithms implemented in MAS5
(microarray suite 5 from Affymetrix) or D-chip [1]. The
decision of whether the detection threshold is set to 10%
or 20% (for example) will change the number of signifi-
cant genes when the analysis is followed by the use of a
parametric test with multiple testing corrections (for
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example). How predictable the imposition of such thresh-
olds, on the composition of the output, is not clear.
A recent method to identify significant genes is "Signifi-
cance Analysis of Microarrays" (SAM)[2]. An ISI search
indicates that SAM is the most popular method employed
for microarray analysis (635 citations of the original pub-
lication as of October 2004). In SAM, the relative differ-
ence (d(i)) is compared to the distribution of d(i)
following random permutation of the sample categories.
For each d(i), a certain proportion of all genes in the per-
mutation set (control set) will be found to be 'significant'
by chance and this parameter is then used to calculate a
"False Discovery Rate" (FDR). This is presented as a q
value for each gene in the final list of significant genes.
The q-values are influenced by the variability in the data
set. This implies that changes in the entire data set compo-
sition will affect the d(i) distribution in the permuted con-
trol set and thus the q-value assigned to a given gene. To
what extent this alters the final output when using SAM or
subsequent post-hoc analysis has so far not been dis-
cussed. As SAM is arguably the most widely utilized
method in the microarray analysis field, we felt it was crit-
ical to evaluate these considerations.
The number of reported significant genes is influenced by 
the FC setting within SAM and the use of "Present/Absent" 
calls for data inclusion
The first point to emphasise is that we are examining the
effect of a variable FC setting, implemented in the Excel
SAM, on a final gene list with a fixed 1.5 FC criteria. Our
principle findings can be extended to any relevant final FC
criteria but in the example we provide we have focused on
a 1.5 FC criteria, for simplicity. When using the FC setting,
implemented in the Excel addin, the researcher selects a
proportion of the all genes on the chip, and this selection
is also utilised for the permutated control data set, how-
ever the settings from the full data set SAM analysis are
maintained (s_0, and pi_0). The FC hurdle setting can
therefore change the resulting q-values as genes that pass
a certain FC when the original sample categories are used,
are less likely to generate high d(i) when the categories are
permutated. To test the extent of this effect, we performed
SAM at several different FC hurdles within Excel and
scored the number of genes reported at the final 1.5 FC
criteria. A difference in the number of genes reported as
significant above the final FC would indicate that by using
the Excel SAM FC restriction setting, during SAM, we
change the outcome by altering the d(i) distribution of
the permutation data set.
We used three different biological data sets to assess how
wide-spread any effects were. The first data set was a
paired data set from a human skeletal muscle study which
examined subjects before and after endurance training
using the U95A-E platform (Affymetrix) [3]. The data was
RMA normalized [4-6] and SAM was performed using dif-
ferent biological sample subgroups (groups were formed
on the basis of a variety of physiological parameters) and
chipset identity (A, B or D). Changing the FC setting in
SAM (Excel) altered the final list of significant genes at the
1.5 FC criteria (Figure 1A–D). Importantly, the effect was
not uniform across all conditions. For some samples a
sequential increase in the FC hurdle in SAM correlated
with an increased number of reported genes (Figure 1A–
B) while under other conditions a very small change in FC
had an apparently random impact on the composition of
the significant gene list (e.g. Figure 1C–D). (The number
of genes that passed each fold change criteria can be found
in [Additional file 1]).
The second data set was derived from an in-vitro mouse
senescence study performed on U74Av2 chips [7] and
normalized using RMA [4-6]. When comparing two of the
time points during the induction of senescence we were
unable to observe any effect of FC selection within SAM
on the yield of significant genes (Figure 2). We believe this
reflected the very low q-values obtained when originally
using SAM, which in turn most likely reflects the low
experimental variation that one can achieve using in-vitro
models.
The third data set is derived from a study of the aging
human brain, containing 21 samples split into two cate-
gories, young and old (unpaired data) [8], and normal-
ised using D-chip [1]. When varying the FC hurdle within
SAM we again saw a large impact on the number of genes
reported as being significant, above the 1.5 FC criteria (a
q-value threshold of 1% was considered statistically sig-
nificant similarly to the original report) (Figure 3A–B).
The 'significant' gene list increased from 283 genes when
using no FC hurdle (during SAM in Excel) to a maximum
of 465 significant genes (67% more) when using a 1.51
FC hurdle within Excel SAM (Figure 3A).
A similar effect was observed when we examined the
methods utilised by the original authors (20% "Present"
call by D-chip). No FC hurdle generates 314 significant
genes and a 1.51 FC generates 538 genes (Figure 3B). This
is a 71% increase in "significant" genes associated with
aging in human brain, despite the fact that the FC hurdle
utilised in SAM was actually greater than the final FC of
1.5! Similar effects arise when other final FC criterions are
used during SAM. For example if we only consider the sig-
nificant genes that pass a final FC >2 criteria in the aging
brain study, then 5% more >2 FC genes can be found if the
FC hurdle within SAM is set to 2.0 compared to 1.5.
Clearly, genes that are modulated to a large extent may be
of high biological interest and thus our observation is
important. Also, there are 73 more significant genes at theBMC Bioinformatics 2005, 6:129 http://www.biomedcentral.com/1471-2105/6/129
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FC hurdle of 1.51 if the reduced data set is used compared
the full data set (less genes in the data set gave more sig-
nificant genes). This indicates that Present/Absent filter-
ing also influences the outcome of the analysis, in this
case increasing the number of genes defined as being
modulated.
Changing the FC setting in SAM changes the reported q-
value
The analysis presented above demonstrates that the q-
value obtained for a specific gene depends on the FC hur-
dle applied during SAM in Excel. To monitor the q-values
generated, for individual genes, we obtained the q-values
FC effects on the endurance training data set Figure 1
FC effects on the endurance training data set: SAM analysis was used at various fold changes studying the exercise data 
set while scoring genes with a q-value of <0.05 and FC>1.5. This was done to asses the effect of the fold change option in the 
SAM Excel addin on genes reported as significant at a higher fold change. The figure shows the number of scored genes using 4 
different chip and sample combinations: (A) All eight subjects before and after training (totally 16 arrays) were compared in a 
paired analysis using the U95A chips. (B) All eight subjects before and after training (totally 16 arrays) were compared in a 
paired analysis using the U95B chips. (C) The reduced group consisting of low four low responders (totally 8 arrays) were 
compared in a paired analysis using the U95B chips. (D) The reduced group consisting of low four low responders (totally 8 
arrays) were compared in a paired analysis using the U95D chips.
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during all SAM calculation using various FC hurdles for all
genes that were reported as significant at the 1.51 FC set-
ting (538 genes) in the brain aging study (Figure 4A). The
highest q-value for a subset of the genes that passed the
final fold change criteria was 3.6% when SAM was per-
formed with a 1.0 FC hurdle. The same genes appear as
being significant when the "optimal" (in the sense that
these setting produced the largest significant gene list)
Excel SAM FC hurdle setting 1.51 is used while the highest
q-value reported was now only 0.97%.
Running SAM using different FC settings can change data 
interpretation
Often the main reason for carrying out a microarray exper-
iment is to gain greater insight into the molecular proc-
esses that contribute to a complex biological phenotype.
One standard method for carrying out such analysis is the
use of gene-grouping, such as Gene ontology classification
[9]. To address whether the biological interpretation may
be influenced, we compared overrepresentation of classi-
fications using EASE [10]. We selected the 314 genes and
the 538 genes obtained in the brain aging study using the
1.0 and a 1.51 FC hurdles (described above) and calcu-
lated the overrepresented classifications. There was a con-
siderable difference in the number of significantly over-
represented classifications identified by EASE (figure 4B).
35 classifications were overrepresented in both gene lists,
8 were found in the GO analysis of the 1.0 FC list and 29
FC effects on the senescence data set Figure 2
FC effects on the senescence data set: SAM analysis 
was used at various fold changes using the senescence data 
set while scoring genes with a q-value of <0.01 and FC>1.5. 
A comparison between non-senescent cells and senescent 
cells was used (two replicates of the senescent cells and four 
replicates of the non-senescent cells).
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FC effects on the brain aging data set Figure 3
FC effects on the brain aging data set: SAM analysis at 
various fold changes using the brain aging data set (11 old 
samples and 10 young samples) while scoring genes with a q-
value of <0.01 and FC>1.5. We used both the full data set 
and the reduced data set suggested by the authors. (A) The 
full data set. (B) The reduced data set (20% "present" calls by 
D-chip").
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were unique to the 1.51 FC list. We feel it is unlikely that
greater inclusion of randomly determined genes (i.e. false
positives) would give rise to a significant increase in statis-
tically enriched functional groups. This indicates that
both the number of genes and the interpretation may be
substantially altered by arbitrary data filtering, as exempli-
fied by the use of the FC hurdle during the operation of
Excel SAM or through the application of present-absent
calls using e.g. D-chip.
Conclusion
The average researcher is highly dependent on the use of
'standard procedures' for their microarray analysis. An
arbitrary filtering option in the Microsoft Excel Addin (we
have called this the FC hurdle to distinguish from FC cri-
teria – which is the final  FC value selected by the
researcher, to define a functionally significant change in
gene expression) or data exclusion (e.g. present or absent
call thresholds) can impact on a study, in a less than pre-
dictable manner. A clear problem also arises when SAM is
utilised on different software platforms. In the R package
Siggenes, no FC hurdle criteria can be made unless an addi-
tional programming function is implemented by the indi-
vidual researcher. This is in contrast to the more widely
used Microsoft Excel SAM Addin where the researcher can
introduce a FC hurdle prior to the q-value calculations
(while the SAM algorithm maintains the initial parame-
ters from the analysis of the full data set). It is often
unclear in the literature if SAM was performed in Excel or
R; and if an FC hurdle was applied within SAM or if the
fold change criteria was introduced after completing the
operation of SAM, in EXCEL.
Indeed, one might question how robust the SAM method-
ology is, if it is heavily dependent on both pre SAM data
selection and within SAM (Excel) data filtering. However,
one of the appreciated strengths of SAM is that the real
data set is used to estimate experimental variation. One
could also question whether it is valid to reduce the data
set prior to using SAM. It would seem intuitive that much
of the data being removed using a FC hurdle during SAM
operation would be below an acceptable response level to
be considered as being biologically relevant. However, the
FC hurdle may also remove data that is essential for an
accurate estimation of the experimental variation. The
challenge would then be to remove 'genuine' noise from
non-expressing genes without removing genes that are
genuinely expressed and necessary to approximate the
data set variation. The effects will be pronounced in data
sets demonstrating a large range of gene expression FC's or
where significant inter experimental variation exists. It is
clear, that investigators must be made aware that the
impact of 'qualification criteria for inclusion' and 'out-put
filtering' is less than predictable, when using SAM.
Methods
Data sets
Three data sets were used. The first is a human skeletal
muscle study, comparing eight subjects across the U95A-E
Affymetrix chips before and after endurance training [3].
A subset of this data set can be derived by creating a low
responder group based on their improvement upon train-
ing. This subset is referred to as the low responder group
in figure 1. The data can be obtained from the authors
(JAT). The second data set is a part of an mouse in-vitro
FC effects individual q-values: Figure 4
FC effects individual q-values: q-values of all genes 
scored as significant in the brain aging study (reduced data 
set) at FC 1.51 at other FC settings. Genes only acquires dis-
crete q-values and all 538 genes are shown, but overlap. (B) 
Running SAM with different FC settings changes the 
biological interpretation: Venn diagram comparing the 
number of significantly overrepresented classifications (EASE 
score <0.05) using the reduced brain aging data set analysed 
either with a 1.0 FC setting (314 genes) or a 1.5 FC setting 
(538 genes).
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senescence study performed on U74Av2 (Affymetrix) [7].
Two conditions were selected for comparison: EpiA1-ts58
cells at the basal condition and EpiA1-ts58 cells after 72
hours of senescence induction. This data set can be
downloaded from the journal web site in a MAS5
(Affymetrix microarray suite 5) normalised format or will
be distributed in RMA normalised format by the authors
(OL). The third data set is a brain aging study performed
on the U95A chip (Affymetrix) and normalised using D-
chip [8]. The authors separated their data set into two
groups: young (<43 years old) and old (>72 years old)
and we used the same grouping in our analysis. The
authors further used a data discrimination based on
"present" calls given by D-chip (20% present in all sam-
ples). We used both the full data set and the 20% data set
which is referred to as the reduced data set. The data set
can be access at GEO, accession number GSE1572.
SAM analysis
SAM analysis was performed using the Microsoft Excel
addin v1.21. The analysis was performed using different
settings of the "Fold change". We also performed SAM
analysis using the R (R-project.org) package "siggenes" as
a comparison to the Excel addin without using the fold
change setting with consistent results.
Classification analysis
To look for overrepresented classifications we used EASE
[10]. We used all possible classifications and considered a
classification as positively overrepresented if the EASE
score was lower then 0.05.
Abbreviations
SAM – significance analysis of microarrays
FDR – false discovery rate
FC – fold change
EF – extraction factor
MAS5 – microarray suite 5
RMA – robust multi array average
GEO – gene expression omnibus
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